Neutralizing Type I Interferon Autoantibodies in Japanese Patients With Severe COVID-19

Mostrar otras versiones (1)

PURPOSE: Autoantibodies (aAbs) to type I interferons (IFNs) have been found in <1% of individuals under the age of 60 in the general population, with the prevalence increasing among those over 65. Neutralizing autoantibodies (naAbs) to type I IFNs have been found in at least 15% of patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Eto, Shohei, Nukui, Yoko, Tsumura, Miyuki, Nakagama, Yu, Kashimada, Kenichi, Mizoguchi, Yoko, Utsumi, Takanori, Taniguchi, Maki, Sakura, Fumiaki, Noma, Kosuke, Yoshida, Yusuke, Ohshimo, Shinichiro, Nagashima, Shintaro, Okamoto, Keisuke, Endo, Akifumi, Imai, Kohsuke, Kanegane, Hirokazu, Ohnishi, Hidenori, Hirata, Shintaro, Sugiyama, Eiji, Shime, Nobuaki, Ito, Masanori, Ohge, Hiroki, Kido, Yasutoshi, Bastard, Paul, Casanova, Jean-Laurent, Tanaka, Junko, Morio, Tomohiro, Okada, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923117/
https://www.ncbi.nlm.nih.gov/pubmed/35291303
http://dx.doi.org/10.21203/rs.3.rs-1430985/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923117/
https://www.ncbi.nlm.nih.gov/pubmed/35291303
http://dx.doi.org/10.21203/rs.3.rs-1430985/v1

Ejemplares similares